NO20073737L - Hjelp for influensavirus - Google Patents
Hjelp for influensavirusInfo
- Publication number
- NO20073737L NO20073737L NO20073737A NO20073737A NO20073737L NO 20073737 L NO20073737 L NO 20073737L NO 20073737 A NO20073737 A NO 20073737A NO 20073737 A NO20073737 A NO 20073737A NO 20073737 L NO20073737 L NO 20073737L
- Authority
- NO
- Norway
- Prior art keywords
- influenza
- cell
- nucleic acid
- virus
- influenza virus
- Prior art date
Links
- 241000712461 unidentified influenza virus Species 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 229960003971 influenza vaccine Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04078527 | 2004-12-24 | ||
US64100305P | 2005-01-04 | 2005-01-04 | |
PCT/EP2005/057092 WO2006067211A1 (fr) | 2004-12-24 | 2005-12-22 | Obtention du virus grippal |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073737L true NO20073737L (no) | 2007-09-21 |
Family
ID=34928779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073737A NO20073737L (no) | 2004-12-24 | 2007-07-18 | Hjelp for influensavirus |
Country Status (20)
Country | Link |
---|---|
US (2) | US7959930B2 (fr) |
EP (2) | EP1831357B1 (fr) |
JP (2) | JP5620048B2 (fr) |
KR (1) | KR101272487B1 (fr) |
CN (1) | CN101379183B (fr) |
AU (1) | AU2005318087B2 (fr) |
BR (1) | BRPI0518568A2 (fr) |
CA (1) | CA2592439C (fr) |
DK (1) | DK1831357T3 (fr) |
ES (1) | ES2395813T3 (fr) |
HK (1) | HK1125674A1 (fr) |
IL (1) | IL183888A (fr) |
MX (1) | MX2007007889A (fr) |
NO (1) | NO20073737L (fr) |
NZ (1) | NZ556061A (fr) |
PT (1) | PT1831357E (fr) |
RU (2) | RU2435855C2 (fr) |
TW (2) | TWI495724B (fr) |
WO (1) | WO2006067211A1 (fr) |
ZA (1) | ZA200705145B (fr) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101921732A (zh) | 2001-01-19 | 2010-12-22 | 维洛诺瓦蒂夫公司 | 在易感哺乳动物中引起呼吸道疾病的病毒 |
IL163646A0 (en) | 2002-02-21 | 2005-12-18 | Vironovative Bv | Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus |
US7959930B2 (en) * | 2004-12-24 | 2011-06-14 | Abbott Biologicals B.V. | Rescue of influenza virus |
US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
BRPI0612268A2 (pt) * | 2005-06-21 | 2009-01-27 | Medimmune Vaccines Inc | Ácido nucleico isolado, vetor de expressço, mÉtodos para produzir um rna genâmico da influenza, para produzir um vÍrus da influenza recombinante, para gerar um vÍrus de rna segmentado de filamento negativo recombinante nas cÉlulas caninas cultivadas e para gerar partÍculas virais da influenza infecciosa em cÉlulas caninas cultivadas, cÉlula, e, vÍrus |
US20090304742A1 (en) | 2005-11-04 | 2009-12-10 | Novartis Vaccines And Diagnostics Srl | Influenza vaccines with reduced amount of emulsion adjuvant |
CA2628424A1 (fr) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics S.R.L. | Vaccins influenza avec adjuvant comprenant des agents d'induction de cytokines |
WO2007052061A2 (fr) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Emulsions a tensioactif a phase aqueuse libre pour adjuver des vaccins antigrippaux sous-unitaires |
PT2368572T (pt) | 2005-11-04 | 2020-06-16 | Seqirus Uk Ltd | Vacinas com adjuvante dotadas de antigénios não-virião preparados a partir de vírus da gripe cultivado em cultura celular |
NZ568211A (en) | 2005-11-04 | 2011-11-25 | Novartis Vaccines & Diagnostic | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
KR20080089663A (ko) | 2006-01-27 | 2008-10-07 | 노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 | 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신 |
AU2007231027B2 (en) | 2006-03-24 | 2013-10-03 | Novartis Influenza Vaccines Marburg Gmbh | Storage of influenza vaccines without refrigeration |
AU2007245192B2 (en) | 2006-03-31 | 2012-04-12 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
AU2007297178B2 (en) | 2006-09-11 | 2014-07-24 | Novartis Ag | Making influenza virus vaccines without using eggs |
WO2008068631A2 (fr) | 2006-12-06 | 2008-06-12 | Novartis Ag | Vaccins comprenant un antigène issu de quatre souches du virus grippal |
WO2008156778A2 (fr) | 2007-06-18 | 2008-12-24 | Tokiko Watanabe | Virus mutants de protéine m2 de la grippe comme vaccins vivants atténués contre la grippe |
NZ582595A (en) | 2007-06-27 | 2012-07-27 | Novartis Ag | Low-additive influenza vaccines |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
NZ587798A (en) | 2008-03-18 | 2013-06-28 | Novartis Ag | Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer |
CA2752039A1 (fr) | 2009-02-10 | 2010-08-19 | Novartis Ag | Regimes de vaccin antigrippal pour souches liees a une pandemie |
CN102307590A (zh) | 2009-02-10 | 2012-01-04 | 诺华有限公司 | 具有减少量的角鲨烯的流感疫苗 |
WO2010092477A1 (fr) | 2009-02-10 | 2010-08-19 | Novartis Ag | Vaccins contre l'influenza possédant des quantités accrues d'antigène h3 |
DE102010018462A1 (de) | 2009-04-27 | 2011-04-07 | Novartis Ag | Impfstoffe zum Schutz gegen Influenza |
CN102666860B (zh) | 2009-07-31 | 2015-06-17 | 诺华股份有限公司 | 反向遗传系统 |
WO2011056591A1 (fr) | 2009-10-26 | 2011-05-12 | Warf - Wisconsin Alumni Research Foundation | Virus recombinants de la grippe de titre élevé à réplication améliorée dans les cellules vero |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
EA201201620A1 (ru) * | 2010-06-02 | 2013-07-30 | Авир Грин Хилз Байотекнолоджи Рисерч Дивелопмент Трейд Аг | Способ получения рнк-вируса |
FR2962739B1 (fr) * | 2010-07-13 | 2014-01-31 | Univ Claude Bernard Lyon | Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza |
US20140248320A1 (en) | 2011-10-20 | 2014-09-04 | Novartis Ag | Adjuvanted influenza b virus vaccines for pediatric priming |
GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
US10080794B2 (en) | 2013-03-15 | 2018-09-25 | University Of Maryland, College Park | Swine influenza viruses and constructs and uses thereof |
EP3022296B1 (fr) | 2013-07-15 | 2022-12-28 | Wisconsin Alumni Research Foundation | Virus influenza recombinés à titre élevé avec augmentation de la réplication dans les oeufs ou les cellules de la lignée vero ou mdck |
WO2015196150A2 (fr) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations conférant une stabilité génétique à des gènes supplémentaires dans des virus de la grippe |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
WO2016201127A1 (fr) * | 2015-06-09 | 2016-12-15 | Sanofi Pasteur, Inc. | Procédés d'optimisation de séquences nucléotidiques codant pour des protéines de la grippe ingéniérisées |
WO2016207853A2 (fr) | 2015-06-26 | 2016-12-29 | Seqirus UK Limited | Vaccins contre la grippe à correspondance antigénique |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
WO2017005880A1 (fr) | 2015-07-07 | 2017-01-12 | Seqirus UK Limited | Dosages de la puissance de la grippe |
JP2019510481A (ja) | 2016-02-19 | 2019-04-18 | ウィスコンシン アルムニ リサーチ ファンデイション | ワクチン開発のための改善されたb型インフルエンザウイルス複製 |
US11241492B2 (en) | 2019-01-23 | 2022-02-08 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to genes in influenza viruses |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
US11390649B2 (en) | 2019-05-01 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
EP4022046A2 (fr) | 2019-08-27 | 2022-07-06 | Wisconsin Alumni Research Foundation (WARF) | Virus de la grippe recombinants à ha stabilisé pour réplication dans des oeufs |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001634A (en) * | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
US5854037A (en) * | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US6887699B1 (en) * | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
US6544785B1 (en) * | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
US8715940B2 (en) * | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
DK1185615T3 (da) | 1999-04-06 | 2007-11-05 | Wisconsin Alumni Res Found | Rekombinante influenzavirus til vacciner og genterapi |
DE122007000070I1 (de) | 1999-07-14 | 2008-01-31 | Sinai School Medicine | In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren |
MXPA02001177A (es) * | 1999-08-02 | 2002-07-02 | Wyeth Corp | Recuperacion del virus de las paperas del acido desoxirribonucleico recombinante. |
US6764685B1 (en) * | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
WO2001083794A2 (fr) | 2000-04-28 | 2001-11-08 | St. Jude Children's Research Hospital | Systeme de transfection d'adn servant a generer des virus de la grippe infectieuse |
MXPA02012255A (es) * | 2000-06-23 | 2003-04-25 | American Cyanamid Co | Secuencia de nucleotidos del genoma a/udorn/72(hen2) de influenza. |
IL163646A0 (en) * | 2002-02-21 | 2005-12-18 | Vironovative Bv | Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus |
AU2003231083A1 (en) * | 2002-04-26 | 2003-11-10 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
US7959930B2 (en) * | 2004-12-24 | 2011-06-14 | Abbott Biologicals B.V. | Rescue of influenza virus |
-
2005
- 2005-12-22 US US11/722,769 patent/US7959930B2/en not_active Expired - Fee Related
- 2005-12-22 WO PCT/EP2005/057092 patent/WO2006067211A1/fr active Application Filing
- 2005-12-22 EP EP05825287A patent/EP1831357B1/fr active Active
- 2005-12-22 AU AU2005318087A patent/AU2005318087B2/en not_active Ceased
- 2005-12-22 KR KR1020077017093A patent/KR101272487B1/ko not_active IP Right Cessation
- 2005-12-22 BR BRPI0518568-8A patent/BRPI0518568A2/pt not_active IP Right Cessation
- 2005-12-22 MX MX2007007889A patent/MX2007007889A/es active IP Right Grant
- 2005-12-22 ES ES05825287T patent/ES2395813T3/es active Active
- 2005-12-22 JP JP2007547535A patent/JP5620048B2/ja not_active Expired - Fee Related
- 2005-12-22 EP EP10182258A patent/EP2295542B1/fr not_active Not-in-force
- 2005-12-22 PT PT58252875T patent/PT1831357E/pt unknown
- 2005-12-22 NZ NZ556061A patent/NZ556061A/en not_active IP Right Cessation
- 2005-12-22 RU RU2007128336/10A patent/RU2435855C2/ru not_active IP Right Cessation
- 2005-12-22 CA CA2592439A patent/CA2592439C/fr not_active Expired - Fee Related
- 2005-12-22 DK DK05825287.5T patent/DK1831357T3/da active
- 2005-12-22 CN CN2005800447512A patent/CN101379183B/zh not_active Expired - Fee Related
- 2005-12-23 TW TW101113590A patent/TWI495724B/zh not_active IP Right Cessation
- 2005-12-23 TW TW094146438A patent/TWI402344B/zh not_active IP Right Cessation
-
2007
- 2007-06-13 IL IL183888A patent/IL183888A/en not_active IP Right Cessation
- 2007-06-21 ZA ZA200705145A patent/ZA200705145B/xx unknown
- 2007-07-18 NO NO20073737A patent/NO20073737L/no not_active Application Discontinuation
-
2009
- 2009-04-30 HK HK09104018.1A patent/HK1125674A1/xx not_active IP Right Cessation
-
2011
- 2011-04-15 US US13/088,120 patent/US20120156241A1/en not_active Abandoned
- 2011-05-31 RU RU2011122117/10A patent/RU2011122117A/ru not_active Application Discontinuation
-
2012
- 2012-03-22 JP JP2012065345A patent/JP5702321B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073737L (no) | Hjelp for influensavirus | |
EP1697521A4 (fr) | Systeme a plasmides multiples pour la production du virus de la grippe | |
DK1685243T3 (da) | Immortaliserede fuglecellelinjer til virusproduktion | |
AU2007245192B2 (en) | High titer recombinant influenza viruses for vaccines | |
CY1121159T1 (el) | Μη-ενσωματουμενοι λεντiϊικοι φορεις | |
WO2005115448A8 (fr) | Systeme multiplasmide pour la production d'un virus grippal | |
WO2006071563A3 (fr) | Lignee cellulaire mdck non-oncogene destinee a propager des virus | |
PE20140867A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
EP4349405A3 (fr) | Vaccins contre le virus respiratoire | |
BR112012000942B8 (pt) | processos para a produção de poliovírus, e para produzir uma vacina contra pólio | |
EA200970271A1 (ru) | Получение вакцин против вируса гриппа без использования куриных эмбрионов | |
EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
BR112015023424A2 (pt) | construto de expressão engenheirado, método para aprimoramento de produção de rna ou proteína, vetor, célula, hospedeira bacteriana, sistema de cultura de célula para síntese in vivo de dsrna, composição e método para controlar uma infestação de pragas de invertebrados ou para inibir a propagação de uma doença viral em uma população de plantas, e terminador transcricional | |
WO2006127150A3 (fr) | Compositions a base de cellules dendritiques et methodes associees | |
NZ597401A (en) | Chimeric influenza virus-like particles comprising hemagglutinin | |
CY1111378T1 (el) | Προερχομενα απο κυτταρα ιικα εμβολια με χαμηλα επιπεδα υπολειμματικου κυτταρικου dna | |
WO2006094974A3 (fr) | Stabilisateur defini chimiquement | |
WO2009080806A3 (fr) | Virus influenza modifié | |
MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
AU2014202470A1 (en) | High titer recombinant influenza viruses for vaccines | |
IN2012DN01577A (fr) | ||
WO2018097603A3 (fr) | Composition immunogène de protéine s du coronavirus du syndrome respiratoire du moyen-orient et son procédé de préparation | |
CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
WO2014063016A8 (fr) | Procédé de génération d'animaux génétiquement supérieurs | |
AR102803A1 (es) | Vacunas de reovirus aviar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ERASMUS UNIVERSITY MEDICAL CENTER, NL Owner name: ABBOTT BIOLOGICALS BV, NL |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |